The antagonist, pJAK2 (1001‐1013), is a SOCS1 and SOCS3 inhibitor that binds to the KIR region, blocking their inhibitory activity in different viral infections, such as HSV‐1 and influenza A [63, 64]. The gene discussed is SOCS1; the disease is viral infectious disease.